Stem Cell Therapy Market | Size | Share | Forecast 2018 to 2024

13/giu/2018 09:44:36 PBIGP Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.


Stem Cell Therapy Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 Developing mindfulness about the intensity of foundational microorganisms in illness administration, improvement of cutting edge quality based investigation methods and increment out in the open, private interests in undeveloped cell look into are going about as development drivers for undifferentiated organism treatment showcase. Furthermore, distinguishing proof of new foundational microorganism lines and advancement of framework for undifferentiated organism managing an account and preparing are driving the development of the worldwide undeveloped cell treatment showcase. Be that as it may, moral issues associated with undifferentiated cells research, for example, decimation of human incipient organisms, religious convictions are considered as barriers for adjustment of immature microorganism treatment by patients. Be that as it may, stringent controls to lead trials on people, high-cost of research and capacity of foundational microorganisms are some controlling elements for immature microorganism treatment advertise.


A sample of this report is available upon request @



Stem cell therapy market has been segmented on the basis of treatment mode, cell types, application, technology, and end-user


Based on treatment, stem cell therapy market is segmented into

·         Allogeneic

·         Autologous


Based on cell type, stem cell therapy market is segmented into

·         Adult Stem cells

·         Induced Pluripotent Stem cells

·         Human Embryonic Stem Cells

·         Others


Based on technology, stem cell therapy market is segmented into

·         Cell Production

·         Cell Acquisition

·         Cryopreservation


Based on end-user, stem cell therapy market segmented into

·         Hospitals

·         Ambulatory Centers

·         Research Centers


To view TOC of this report is available upon request @



Stakeholders in stem cell therapy such as academic institutions and research firms are collaborating in development of stem cell therapy and industry collaborations also projecting enormous growth of stem cell therapy market. For instance, in November 2015, Cellular Dynamics International, Inc. (FUJIFILM) collaborated with Roche to supply iCell (CDI’s induced pluripotent stem cell derived) products that enables in identification of novel drug candidates at the early stages of drug discovery. Similarly, in May 2017, Magenta Therapeutics, entered into strategic partnership with Be The Match BioTherapies, to improve and expand the use of curative stem cell transplantation.


Need more information about this report @



Geographically stem cell therapy market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Among the regions, North America dominates global stem cell therapy market due to factors such as increasing prevalence of chronic diseases, growing awareness, and rising investment in research and development activities. In Asia Pacific region, due to the favourable government policies, development healthcare infrastructure, industry collaborations in research and developments expected to boost stem cell therapy market. For instance, in April 2017, Plasticell, a developer of stem cell technologies and cell-based therapies, has announced that it has signed agreements with the Agency for Science, Technology and Research (A*STAR), Singapore,  and the Nanyang Technological University (NTU), Singapore, to progress its therapeutic stem cell pipeline.


Some of the players in stem cell therapy market are Cytori Therapeutics Inc. (U.S.), Fibrocell Science (U.S.), Cellartis AB (Cellectis) (France), BioTime, Inc. (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific (U.S.), STEMCELL Technologies Inc. (Canada), Fujifilm Holdings Corporation (Japan), Vericel Corporation (Aastrom Bioscience) (U.S.), Brainstorm cell therapeutics (U.S.), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), Celgene Corporation (U.S.), and Osiris Therapeutics, Inc. (U.S.) to name a few.


Get access to full summary @


About Precision Business Insights


Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.


Contact to Precision Business Insights,


Kemp House,

152 – 160 City Road,

London EC1V 2NX




Toll Free (US): +1-866-598-1553

Website @


Image & Author Bio:







blog comments powered by Disqus è un servizio offerto da Factotum Srl